Cannabinoids as cancer therapy will play an important role in future. So far, cannabinoids have mostly been used to treat symptoms such as nausea and pain, which in many cases brings relief to the patient. But a cancer therapy with cannabinoids can have an even greater potential in the treatment of tumors. Although research on this topic is still in its infancy, it will play an increasingly important role in the future, as there are now many indications that cannabinoid cancer therapy can be a real, gentle new form of therapy for patients.
maintrac for the selection of the best working Cannabinoids
With maintrac®, the tumour cell-killing properties of cannabinoids can be tested individually for each patient and a well-founded therapy option can be found. The aim of our research is to develop a portfolio of specially compiled cannabinoid extracts that have particularly good antitumor properties. In initial preliminary tests, CBD was able to demonstrate its cell-killing properties.
This would take the field of significantly more tolerable chemotherapy one step further. Together with our partners, Charité in Berlin and maintrac special laboratory, we are developing these new forms.
Modes of action of cannabinoids
The human body has endogenous cannabinoid analogues (anandamide and 2-arachidonylglycerol (2-AG)). These bind to specific receptors on cell surfaces and influence cell function. This receptor group is also called the endocannabinoid system. The binding of cannabinoids to these receptors leads to a variety of different effects depending on the cannabinoid being considered.
- appetitt reduction
- Immune modulating
- sleep promoting
- pain relieving
Forms of delivery for cannabinoid cancer therapy
Cannabis can be delivered to the body in a variety of forms. Here are just a few:
- as a flower for smoking
- as vapes in e-cigarettes
- as cannabis extract dissolved in different carrier oils for oral intake
- as cream for topical applications
- as lozenges
- as dosed food in the form of chocolate, gummies or drink
- as infusion solution
- trans-dermal patches
The DMB deals with the compilation of different cannabinoids for an optimized cannabinoid cancer therapy. Only in combination with the diagnosis of tumor cells and the individually tested sensitivity to different cannabinoids can a well-functioning medication against tumor diseases be found.